Wednesday, April 01, 2015 9:50:38 AM
Keep scanning for sale prices.
IDRA is a perfect example. Great news, stock is down. In fact, below Baker Bro last purchase of $20million worth at $3.75.
Best Green Wishes to All.
The current average broker recommendation for Idera Pharmaceuticals, Inc., according to Zack’s research, is 1.00, based on 2 broker ratings. With 1 being a strong buy and 5 being a strong sell, this means that on a consensus basis, analysts currently see Idera Pharmaceuticals, Inc. as a strong buy. The 12 month target consensus price estimate among these analysts for Idera Pharmaceuticals, Inc. is currently at $7.00.
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM